Mark Schoenberg

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

URGN

Current role

3 calls Latest call 2026-08-05

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	UroGen Pharma Ltd. (URGN)	Chief Medical Officer	$369,607	$167,500	$440,400	—	$180,000	$13,133	$1,170,640
2024	UroGen Pharma Ltd. (URGN)	Chief Medical Officer	$354,240	—	$314,000	—	$202,500	$8,145	$878,885
2023	UroGen Pharma Ltd. (URGN)	Chief Medical Officer	$341,469	$26,250	$519,950	$200,768	$270,000	$2,113	$1,360,550
2022	UroGen Pharma Ltd. (URGN)	Chief Medical Officer	$325,963	—	$30,880	$60,577	$180,000	$2,191	$599,610
2021	UroGen Pharma Ltd. (URGN)	Chief Medical Officer	$284,907	—	$132,420	$312,213	$293,200	$1,398	$1,024,138
2020	UroGen Pharma Ltd. (URGN)	Chief Medical Officer	$185,026	—	$176,460	$92,055	$293,150	$1,767	$948,458
2019	UroGen Pharma Ltd. (URGN)	Chief Medical Officer	$205,000	—	$106,250	$218,054	$270,000	$1,604	$800,908
2018	UroGen Pharma Ltd. (URGN)	Chief Medical Officer	$200,000	$0	$0	$0	$100,000	$0	$300,000
2017	UroGen Pharma Ltd. (URGN)	Chief Medical Officer	$13,636	$75,000	$490,750	$468,708	$6,030	—	$1,054,124

Earnings-call appearances and filed executive appointments or departures, newest first.